Lung Cancer News

The FDA granted fast track designation to TH1902 for treatment of certain patients with sortilin-expressing cancers, according to the agent’s manufacturer.

Female breast cancer has become the most common cancer worldwide, with an estimated 2.3 million new cases diagnosed last year alone, according to the Global Cancer Statistics 2020 report.

Neoadjuvant atezolizumab conferred a 21% major pathologic response rate among patients with resectable stage IB to stage IIIB non-small cell lung cancer.

The FDA granted accelerated approval to tepotinib for treatment of certain patients with metastatic non-small cell lung cancer.

Sotorasib conferred durable clinical benefit for patients with pretreated advanced non-small cell lung cancer who harbor KRAS G12C mutations.

The addition of first-line ipilimumab to pembrolizumab did not improve outcomes for patients with metastatic non-small cell lung cancer who had PD-L1 tumor proportion scores of 50% or greater and no targetable EGFR or ALK aberrations.

Nivolumab significantly prolonged PFS and OS compared with placebo for patients with relapsed malignant mesothelioma, according to findings presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Terence M. Williams, MD, PhD, has been appointed chair of City of Hope’s department of radiation oncology.

Draft U.S. Preventive Services Task Force guidelines that aimed to increase the number of minorities eligible for lung cancer screening may instead exacerbate racial and ethnic disparities, study results showed.

United States Preventive Services Task Force recommended that clinicians ask all adults about tobacco use and provide them with behavioral interventions and even FDA-approved pharmacotherapy to help them quit smoking.